Here, we show that muscle phenotypes in a zebrafish model of FKRP-associated dystroglycanopathy are improved with NAD+ supplementation but not Paxillin overexpression. This evidence concerns the gene FKRP and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.